{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:55:44Z","timestamp":1772150144143,"version":"3.50.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Two common single nucleotide polymorphisms in immunoregulatory genes (TNF G308A, rs1800629 and IL10 T3575A, rs1800890) have been recently reported as risk factors for non\u2013Hodgkin lymphoma (NHL) in a large pooled analysis. We systematically investigated the effects of other established NHL risk factors in relation to the tumor necrosis factor (TNF) G308A or interleukin 10 (IL10) T3575A genotypes. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) from 1,172 cases and 982 population-based controls in a U.S. multicenter study. We investigated NHL overall and two common subtypes [diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma]. NHL risks were increased among those with both an autoimmune condition and the TNF G308A GA\/AA (ORNHL, 2.1; 95% CI, 1.0\u20134.2) or the IL10 T3575A TA\/AA genotype (ORNHL, 1.6; 95% CI, 0.9\u20132.6) compared with individuals without an autoimmune condition and with the common TNF G308A GG or IL10 T3575A TT genotype, respectively; results were similar for DLBCL and follicular lymphoma. We found that elevated DLBCL risk associated with last-born status was more pronounced among those with TNF G308A GA\/AA (ORDLBCL, 2.7; 95% CI, 1.1\u20136.4) or IL10 T3575A TA\/AA (ORDLBCL, 2.9; 95% CI, 1.6\u20135.2). Similarly, elevated DLBCL risk associated with obesity (body mass index, \u226535 versus &amp;lt;25 kg\/m2) was observed only among those with TNF G308A GA\/AA (ORDLBCL, 2.5; 95% CI, 1.1\u20135.7) or IL10 T3575A TA\/AA genotypes (ORDLBCL, 2.0; 95% CI, 1.1\u20133.5). These exploratory results require replication but provide evidence that autoimmune conditions, late birth order, and obesity act partly through a common inflammatory pathway, posing a greater risk to individuals with variant TNF and IL10 genotypes than those with wild-type alleles. [Cancer Res 2007;67(10):5042\u201354]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-4752","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T07:12:30Z","timestamp":1179472350000},"page":"5042-5054","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Immune Mechanisms in Non\u2013Hodgkin Lymphoma: Joint Effects of the <i>TNF<\/i> G308A and <i>IL10<\/i> T3575A Polymorphisms with Non\u2013Hodgkin Lymphoma Risk Factors"],"prefix":"10.1158","volume":"67","author":[{"given":"Sophia S.","family":"Wang","sequence":"first","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[{"name":"2University of Southern California, Los Angeles, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"3Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota;"},{"name":"4University of Iowa, Iowa City, Iowa;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne S.","family":"Colt","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay M.","family":"Morton","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Davis","sequence":"additional","affiliation":[{"name":"5Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Severson","sequence":"additional","affiliation":[{"name":"6Karmanos Cancer Institute and Department of Family Medicine, Wayne State University, Detroit, Michigan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Rothman","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Chanock","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"},{"name":"7Core Genotyping Facility, Advanced Technology Corporation, National Cancer Institute, Gaithersburg, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Hartge","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,5,17]]},"reference":[{"key":"2022061622160024200_B1","doi-asserted-by":"crossref","unstructured":"Engels EA, Cerhan JR, Linet MS, et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol\u20082005; 162: 1153\u201361.","DOI":"10.1093\/aje\/kwi341"},{"key":"2022061622160024200_B2","doi-asserted-by":"crossref","unstructured":"Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer\u20082004; 111: 76\u201380.","DOI":"10.1002\/ijc.20021"},{"key":"2022061622160024200_B3","doi-asserted-by":"crossref","unstructured":"De Sanjose S, Nieters A, Goedert JJ, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer\u20082004; 111: 81\u20135.","DOI":"10.1002\/ijc.11727"},{"key":"2022061622160024200_B4","doi-asserted-by":"crossref","unstructured":"De Sanjose S, Dickie A, Alvaro T, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 944\u20138.","DOI":"10.1158\/1055-9965.944.13.6"},{"key":"2022061622160024200_B5","doi-asserted-by":"crossref","unstructured":"De Sanjose S, Goedert JJ, Marshall V, et al. Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer\u20082004; 90: 2145\u20138.","DOI":"10.1038\/sj.bjc.6601858"},{"key":"2022061622160024200_B6","doi-asserted-by":"crossref","unstructured":"Vajdic CM, Grulich AE, Kaldor JM, et al. Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 1102\u20138.","DOI":"10.1158\/1055-9965.EPI-06-0078"},{"key":"2022061622160024200_B7","doi-asserted-by":"crossref","unstructured":"Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the InterLymph Consortium. Blood\u20082007; 109: 3479\u201388.","DOI":"10.1182\/blood-2006-06-031948"},{"key":"2022061622160024200_B8","doi-asserted-by":"crossref","unstructured":"Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev\u20082005; 14: 925\u201333.","DOI":"10.1158\/1055-9965.EPI-04-0693"},{"key":"2022061622160024200_B9","doi-asserted-by":"crossref","unstructured":"Morton LM, Zheng T, Holford TR, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol\u20082005; 6: 469\u201376.","DOI":"10.1016\/S1470-2045(05)70214-X"},{"key":"2022061622160024200_B10","doi-asserted-by":"crossref","unstructured":"Colt JS, Davis S, Severson RK, et al. Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 251\u20137.","DOI":"10.1158\/1055-9965.EPI-05-0556"},{"key":"2022061622160024200_B11","doi-asserted-by":"crossref","unstructured":"Colt JS, Severson RK, Lubin J, et al. Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology\u20082005; 16: 516\u201325.","DOI":"10.1097\/01.ede.0000164811.25760.f1"},{"key":"2022061622160024200_B12","doi-asserted-by":"crossref","unstructured":"De Roos AJ, Hartge P, Lubin JH, et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res\u20082005; 65: 11214\u201326.","DOI":"10.1158\/0008-5472.CAN-05-1755"},{"key":"2022061622160024200_B13","doi-asserted-by":"crossref","unstructured":"Hughes AM, Armstrong BK, Vajdic CM, et al. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer\u20082004; 112: 865\u201371.","DOI":"10.1002\/ijc.20470"},{"key":"2022061622160024200_B14","doi-asserted-by":"crossref","unstructured":"Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst\u20082005; 97: 587\u201394.","DOI":"10.1093\/jnci\/dji098"},{"key":"2022061622160024200_B15","doi-asserted-by":"crossref","unstructured":"Holly EA, Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol\u20081997; 15: 211\u201322.","DOI":"10.1097\/00042560-199707010-00005"},{"key":"2022061622160024200_B16","unstructured":"Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res\u20081992; 52: 5510\u20135s."},{"key":"2022061622160024200_B17","doi-asserted-by":"crossref","unstructured":"Lim U, Schenk M, Kelemen LE, et al. Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998\u20132000. Am J Epidemiol\u20082005; 162: 953\u201364.","DOI":"10.1093\/aje\/kwi310"},{"key":"2022061622160024200_B18","doi-asserted-by":"crossref","unstructured":"Cerhan JR, Bernstein L, Severson RK, et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control\u20082005; 16: 1203\u201314.","DOI":"10.1007\/s10552-005-0358-7"},{"key":"2022061622160024200_B19","unstructured":"Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol\u20082006; 7: 27\u201338."},{"key":"2022061622160024200_B20","doi-asserted-by":"crossref","unstructured":"Wang SS, Cerhan JR, Hartge P, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res\u20082006; 66: 9771\u201380.","DOI":"10.1158\/0008-5472.CAN-06-0324"},{"key":"2022061622160024200_B21","doi-asserted-by":"crossref","unstructured":"Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood\u20082006; 107: 4101\u20138.","DOI":"10.1182\/blood-2005-10-4160"},{"key":"2022061622160024200_B22","doi-asserted-by":"crossref","unstructured":"Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun\u20082004; 5: 315\u201329.","DOI":"10.1038\/sj.gene.6364055"},{"key":"2022061622160024200_B23","doi-asserted-by":"crossref","unstructured":"Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol\u20082001; 166: 3915\u201322.","DOI":"10.4049\/jimmunol.166.6.3915"},{"key":"2022061622160024200_B24","doi-asserted-by":"crossref","unstructured":"Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature\u20082004; 431: 405\u20136.","DOI":"10.1038\/431405a"},{"key":"2022061622160024200_B25","doi-asserted-by":"crossref","unstructured":"Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 1415\u201321.","DOI":"10.1158\/1055-9965.1415.13.9"},{"key":"2022061622160024200_B26","doi-asserted-by":"crossref","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood\u20081994; 84: 1361\u201392.","DOI":"10.1182\/blood.V84.5.1361.bloodjournal8451361"},{"key":"2022061622160024200_B27","doi-asserted-by":"crossref","unstructured":"Hartge P, Lim U, Freedman DM, et al. Ultraviolet radiation, dietary vitamin D, risk of non-Hodgkin lymphoma (United States). Cancer Causes Control\u20082006; 17: 1045\u201352.","DOI":"10.1007\/s10552-006-0040-8"},{"key":"2022061622160024200_B28","doi-asserted-by":"crossref","unstructured":"Colt JS, Lubin J, Camann D, et al. Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites. J Expo Anal Environ Epidemiol\u20082004; 14: 74\u201383.","DOI":"10.1038\/sj.jea.7500307"},{"key":"2022061622160024200_B29","doi-asserted-by":"crossref","unstructured":"Lubin JH, Colt JS, Camann D, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect\u20082004; 112: 1691\u20136.","DOI":"10.1289\/ehp.7199"},{"key":"2022061622160024200_B30","unstructured":"Garcia-Closas M, Egan KM, Abruzzo J, et al. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev\u20082001; 10: 687\u201396."},{"key":"2022061622160024200_B31","doi-asserted-by":"crossref","unstructured":"Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst\u20082006; 98: 51\u201360.","DOI":"10.1093\/jnci\/djj004"},{"key":"2022061622160024200_B32","doi-asserted-by":"crossref","unstructured":"Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 2069\u201377.","DOI":"10.1158\/1055-9965.EPI-06-0300"},{"key":"2022061622160024200_B33","doi-asserted-by":"crossref","unstructured":"Ranganathan P. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis. Pharmacogenomics\u20082005; 6: 481\u201390.","DOI":"10.2217\/14622416.6.5.481"},{"key":"2022061622160024200_B34","doi-asserted-by":"crossref","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med\u20082005; 165: 2337\u201344.","DOI":"10.1001\/archinte.165.20.2337"},{"key":"2022061622160024200_B35","doi-asserted-by":"crossref","unstructured":"Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis\u20082001; 27: 750\u20136.","DOI":"10.1006\/bcmd.2001.0442"},{"key":"2022061622160024200_B36","doi-asserted-by":"crossref","unstructured":"Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology\u20082005; 37: 409\u201319.","DOI":"10.1080\/00313020500370192"},{"key":"2022061622160024200_B37","doi-asserted-by":"crossref","unstructured":"Bracci PM, Dalvi TB, Holly EA. Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 1287\u201394.","DOI":"10.1158\/1055-9965.EPI-06-0066"},{"key":"2022061622160024200_B38","doi-asserted-by":"crossref","unstructured":"Cozen W, Cerhan JR, Martinez-Maza O, et al. The effect of atopy, childhood crowding and other immune-related factors on non-Hodgkin lymphoma risk. Ca Causes Control. In press 2007.","DOI":"10.1007\/s10552-007-9025-5"},{"key":"2022061622160024200_B39","doi-asserted-by":"crossref","unstructured":"Liew FY. T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol\u20082002; 2: 55\u201360.","DOI":"10.1038\/nri705"},{"key":"2022061622160024200_B40","doi-asserted-by":"crossref","unstructured":"Kemp A, Bjorksten B. Immune deviation and the hygiene hypothesis: a review of the epidemiological evidence. Pediatr Allergy Immunol\u20082003; 14: 74\u201380.","DOI":"10.1034\/j.1399-3038.2003.00017.x"},{"key":"2022061622160024200_B41","doi-asserted-by":"crossref","unstructured":"Spellberg B, Edwards JE, Jr. Type 1\/type 2 immunity in infectious diseases. Clin Infect Dis\u20082001; 32: 76\u2013102.","DOI":"10.1086\/317537"},{"key":"2022061622160024200_B42","doi-asserted-by":"crossref","unstructured":"Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis\u20082001; 184: 777\u201380.","DOI":"10.1086\/322987"},{"key":"2022061622160024200_B43","doi-asserted-by":"crossref","unstructured":"Hurme M, Helminen M. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand J Infect Dis\u20081998; 30: 447\u20139.","DOI":"10.1080\/00365549850161403"},{"key":"2022061622160024200_B44","doi-asserted-by":"crossref","unstructured":"Calle EE, Thun MJ. Obesity and cancer. Oncogene\u20082004; 23: 6365\u201378.","DOI":"10.1038\/sj.onc.1207751"},{"key":"2022061622160024200_B45","doi-asserted-by":"crossref","unstructured":"Chang ET, Hjalgrim H, Smedby KE, et al. Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst\u20082005; 97: 210\u20138.","DOI":"10.1093\/jnci\/dji012"},{"key":"2022061622160024200_B46","doi-asserted-by":"crossref","unstructured":"Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol\u20082006; 6: 772\u201383.","DOI":"10.1038\/nri1937"},{"key":"2022061622160024200_B47","doi-asserted-by":"crossref","unstructured":"McConnachie PR, Zahalsky AC. Immune alterations in humans exposed to the termiticide technical chlordane. Arch Environ Health\u20081992; 47: 295\u2013301.","DOI":"10.1080\/00039896.1992.9938365"},{"key":"2022061622160024200_B48","doi-asserted-by":"crossref","unstructured":"Morton LM, Schenk M, Hein DW, et al. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenet Genomics\u20082006; 16: 537\u201345.","DOI":"10.1097\/01.fpc.0000215071.59836.29"},{"key":"2022061622160024200_B49","doi-asserted-by":"crossref","unstructured":"Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst\u20082005; 97: 199\u2013209.","DOI":"10.1093\/jnci\/dji022"},{"key":"2022061622160024200_B50","doi-asserted-by":"crossref","unstructured":"Chang ET, Smedby KE, Hjalgrim H, et al. Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol\u20082005; 162: 965\u201374.","DOI":"10.1093\/aje\/kwi311"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/10\/5042\/2568379\/5042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/10\/5042\/2568379\/5042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:16:32Z","timestamp":1655428592000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/10\/5042\/532990\/Immune-Mechanisms-in-Non-Hodgkin-Lymphoma-Joint"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,15]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,5,17]]},"published-print":{"date-parts":[[2007,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-4752","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,15]]}}}